Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA

Lookup NU author(s): Emeritus Professor Herbie Newell

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Publication metadata

Author(s): Murray CW, Newell DR, Angibaud P

Publication type: Editorial

Publication status: Published

Journal: MedChemComm

Year: 2019

Volume: 10

Issue: 9

Pages: 1509-1511

Online publication date: 30/08/2019

Acceptance date: 16/08/2019

ISSN (print): 2040-2503

ISSN (electronic): 2040-2511

Publisher: Royal Society of Chemistry

URL: https://doi.org/10.1039/C9MD90044F

DOI: 10.1039/c9md90044f


Share